| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Experimental Studies |
1 From the Department of Diagnostic Radiology, University Hospital of the RWTH Aachen, Pauwelsstrasse 30, 52057 Aachen, Germany (G.S., C.C.A.N.E., G.B.A., S.G., A.B., R.W.G.); and Imaging Technologies and Preclinical Contrast Media Research, MRI, Schering, Berlin, Germany (B.M.). Received September 19, 2000; revision requested November 2; revision received December 11; accepted December 21. Address correspondence to G.S. (e-mail: staatz@rad.rwth-aachen.de).
PURPOSE: To investigate the enhancement of the regional lymph nodes, lymphatic vessels, and thoracic duct after interstitial administration of lymphotropic perfluorinated gadolinium chelates at magnetic resonance (MR) imaging.
MATERIALS AND METHODS: Two perfluorinated gadolinium chelates, gadofluoramide and gadofluorine 8, were injected subcutaneously into the hind legs of 10 pigs, respectively. Both contrast media were studied at doses of 10 and 25 µmol per kilogram of body weight. T1-weighted three-dimensional gradient-echo and maximum intensity projection images were obtained at 1.5 T between 1 and 210 minutes and 24 hours after injection. The contrast agents were qualitatively compared regarding enhancement and depiction of the regional lymph nodes, lymphatic vessels, and thoracic duct.
RESULTS: The inguinal and iliac lymph nodes and lymphatic vasculature enhanced substantially within 10 minutes after subcutaneous administration of both lymphotropic contrast agents. Gadofluorine 8 showed a lymphographic effect superior to that of gadofluoramide. The paraaortic lymph nodes and thoracic duct were best visualized 10–50 minutes after injection of 25 µmol/kg of gadofluorine 8. Lymphatic system enhancement diminished after 2 hours, and the liver and bowel tract enhanced within 24 hours.
CONCLUSION: Interstitial administration of perfluorinated gadolinium chelates offers great potential for T1-weighted MR lymphography with positive enhancement of the lymph nodes and lymphatic vasculature.
Index terms: Animals • Gadolinium, 99.12943 • Lymphatic system, MR, 99.129412, 99.12943 • Lymphography, 99.125 • Magnetic resonance (MR), contrast enhancement, 99.129412, 99.12943
This article has been cited by other articles:
|
|
 |
|
  S. K. Verma, D. G. Mitchell, D. Bergin, R. Mehta, S. Chopra, and D. Choi The Cisterna Chyli: Enhancement on Delayed Phase MR Images after Intravenous Administration of Gadolinium Chelate Radiology, September 1, 2007; 244(3): 791 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Lohrmann, E Foeldi, J-P Bartholomae, and M Langer Gadoteridol for MR imaging of lymphatic vessels in lymphoedematous patients: initial experience after intracutaneous injection Br. J. Radiol., July 1, 2007; 80(955): 569 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sirol, V. V. Itskovich, V. Mani, J. G. S. Aguinaldo, J. T. Fallon, B. Misselwitz, H.-J. Weinmann, V. Fuster, J.-F. Toussaint, and Z. A. Fayad Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging Circulation, June 15, 2004; 109(23): 2890 - 2896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Misselwitz, J. Platzek, and H.-J. Weinmann Early MR Lymphography with Gadofluorine M in Rabbits Radiology, June 1, 2004; 231(3): 682 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Barkhausen, W. Ebert, C. Heyer, J. F. Debatin, and H.-J. Weinmann Detection of Atherosclerotic Plaque With Gadofluorine-Enhanced Magnetic Resonance Imaging Circulation, August 5, 2003; 108(5): 605 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. U. Herborn, T. C. Lauenstein, F. M. Vogt, R. B. Lauffer, J. F. Debatin, and S. G. Ruehm Interstitial MR Lymphography with MS-325: Characterization of Normal and Tumor-Invaded Lymph Nodes in a Rabbit Model Am. J. Roentgenol., December 1, 2002; 179(6): 1567 - 1572. [Abstract] [Full Text] [PDF]
|
|
